Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease

The recent global health emergency caused by the coronavirus disease 2019 (COVID-19) pandemic has taken a heavy toll, both in terms of lives and economies. Vaccines against the disease have been developed, but the efficiency of vaccination campaigns worldwide has been variable due to challenges rega...

書誌詳細
出版年:	Biomolecules
主要な著者:	Balasubramanian Moovarkumudalvan, Anupriya Madhukumar Geethakumari, Ramya Ramadoss, Kabir H. Biswas, Borbala Mifsud
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-11-01
主題:	COVID-19 SARS-CoV-2 main protease structure-based virtual screening molecular docking FDA-approved drugs natural products
オンライン･アクセス:	https://www.mdpi.com/2218-273X/12/12/1754

類似資料

Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors
著者:: Poonam Kalhotra, 等
出版事項: (2021-02-01)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
著者:: Wenfa Zhang, 等
出版事項: (2023-02-01)

Baicalein analogues as prospective SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking-based virtual screening hits
著者:: Qiao Jie Wong, 等
出版事項: (2024-08-01)

A Search for FDA Approved Drugs with Multiple Antiemetic Targets: A Computational-Based Drug Repositioning Study
著者:: Abdulmajeed Yunusa*1, Albashir Tahir1,2
出版事項: (2025-05-01)

Currently Available Non-Balloon Devices
著者:: Hang Lak Lee
出版事項: (2018-09-01)

Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway
著者:: Mahnum Shahzad, 等
出版事項: (2024-12-01)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
著者:: Menghan Gao, 等
出版事項: (2023-07-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
著者:: Moujane Soumia, 等
出版事項: (2020-01-01)

Tadalafil Rescues the p.M325T Mutant of Best1 Chloride Channel
著者:: Kathleen Elverson, 等
出版事項: (2023-04-01)

Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study
著者:: Ishola Abeeb Akinwumi, 等
出版事項: (2023-12-01)

Comparison of approval procedures for medical devices in Europe and the USA
著者:: Vila Wagner Marcel, 等
出版事項: (2019-09-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
著者:: Wei Yu, 等
出版事項: (2021-12-01)

Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method
著者:: Suwicha Patnin, 等
出版事項: (2022-03-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
著者:: Haidar Ali Hamzah, 等
出版事項: (2022-10-01)

Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
著者:: Fangya Li, 等
出版事項: (2023-06-01)

A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
著者:: Alejandro Llanes, 等
出版事項: (2020-12-01)

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
著者:: Vishma Pratap Sur, 等
出版事項: (2021-10-01)

Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
著者:: EBENEZER OLUWAKEMI, 等
出版事項: (2022-06-01)

In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
著者:: Ridwan Abiodun Salaam, 等
出版事項: (2025-03-01)

In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M<sup>pro</sup>)
著者:: Mohamed S. Alesawy, 等
出版事項: (2021-05-01)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
著者:: Annamaria Martorana, 等
出版事項: (2020-07-01)

Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
著者:: Rekha Tamatam, 等
出版事項: (2023-02-01)

An empirical analysis of overall survival in drug approvals by the US FDA (2006–2023)
著者:: Josh Elbaz, 等
出版事項: (2024-04-01)

The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov
著者:: Norring SA, 等
出版事項: (2024-04-01)

A review of new drugs approved by the food and drug administration in 2022
著者:: Arjun Swaminathan, 等
出版事項: (2023-10-01)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
著者:: Rohan R. Narkhede, 等
出版事項: (2020-06-01)

Deciphering the Molecular Interaction Process of Gallium Maltolate on SARS-CoV-2 Main and Papain-Like Proteases: A Theoretical Study
著者:: Kevin Taype-Huanca, 等
出版事項: (2024-04-01)

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
著者:: Daoud Safa, 等
出版事項: (2021-06-01)

Review of approvals and recalls of US specific medical devices in general and plastic surgery
著者:: Aashka Shah, 等
出版事項: (2023-03-01)

Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor
著者:: Xiaohui Hu, 等
出版事項: (2022-09-01)

Structural basis for the inhibition of coronaviral main proteases by PF-00835231
著者:: Zhou Xuelan, 等
出版事項: (2024-07-01)

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors
著者:: Antonella Messore, 等
出版事項: (2024-05-01)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
著者:: Mehdi Oubahmane, 等
出版事項: (2023-04-01)

Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach
著者:: Oluwasayo Peter Abodunrin, 等
出版事項: (2022-01-01)

Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
著者:: Aniruddhya Mukherjee, 等
出版事項: (2023-07-01)

Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran
著者:: Nathaphat Harnkit, 等
出版事項: (2022-09-01)

Molecular docking study and molecular dynamics simulation of spice metabolites against main protease enzymes and NSP3 macrodomain SARS CoV-2
著者:: Purwaniati Purwaniati, 等
出版事項: (2022-03-01)

In Silico Study of FDA-Approved Drugs on <i>Leishmania infantum</i> CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis
著者:: Juan Diego Guarimata, 等
出版事項: (2024-11-01)

Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2
著者:: Anthi Petrou, 等
出版事項: (2022-03-01)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
著者:: Lukas van de Sand, 等
出版事項: (2021-04-01)